Clinical trial
Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized…
NCT00178269 · University of Rochester, Other · Completed
Key facts
| NCT number | NCT00178269 |
|---|---|
| Title | Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix |
| Official title | A Phase Ii Clinical Study Using Weekly Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix |
| Lead sponsor | University of Rochester, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cervix Neoplasm |
| Intervention type | Drug, Procedure |
| Interventions | docetaxel, Radiation Therapy |
| Start date | Jan 1, 2005 |
| Primary completion | Jun 1, 2006 |
| First posted | Sep 15, 2005 |
| Last update posted | May 19, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: